• 1
    Flanders. Feline aortic thromboembolism. Compend Contin EducPracVet 1986;8:473484.
  • 2
    Fox PR. Feline thromboembolism associated with cardiomyopathy. Proc Am Coll Vet Intern Med 1987;5:714718.
  • 3
    Helenski CA, Ross JN. Platelet aggregation in feline cardiomyopathy. J Vet Int Med 1987;1:2428.
  • 4
    Imhoff RK. Production of aortic occlusion resembling acute aortic embolism syndrome in cats. Nature 1961;192:979980.
  • 5
    Butler JC. An investigation into the relationship of an aortic embolus to posterior paralysis in the cat. J Sm Anim Prac 1971;12:141158.
  • 6
    Schaub RG, Meyers KM, Sande RD, et al. Serotonin as a factor in depression of collateral blood flow following experimental arterial thrombosis. J Lab Clin Med 1977;90:645653.
  • 7
    Schaub RG, Gates K., Roberts R. Platelet inhibitory drugs improve collateral flow after aortic thrombosis. Thromb Haemost 1981;262:4449.
  • 8
    Greene CE. Effects of aspirin and propranolol on feline platelet aggregation. Am J Vet Res 1985;46:18201823.
  • 9
    Fox PR. Feline myocardial disease. In: FoxPR, ed. Canine and Feline Cardiology. New York : Churchill Livingstone; 1988:454459.
  • 10
    Pion PD, Kittleson MD. Therapy for feline aortic thromboembolism. In: KirkRW, ed. Current Veterinary Therapy X Small Animal Practice. Philadelphia , PA : Saunders; 1989:295301.
  • 11
    Rawlings CA. Pulmonary arteriography and hemodynamics during feline heartworm disease: Effect of aspirin. J Vet Intern Med 1990;4:285291.
  • 12
    Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988;77:721730.
  • 13
    Dzau VJ, Packer M., Lilly LS, et al. Prostaglandins in severe congestive heart failure. N Eng J Med 1984;310:347352.
  • 14
    Oliver JA, Sciacca R., Pinto J., et al. Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. J Clin Invest 1981;67:229237.
  • 15
    Packer M. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Circ 1988:77:164173 (suppl 1).
  • 16
    Horton R., Zipser R., Fichman M. Prostaglandins, renal function, and vascular regulation. Med Clin North Am 1981;65:891914.
  • 17
    Dyerberg J., Bang HO, Stoffersen E., et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978;2:117119.
  • 18
    Siess W., Roth P., Scherer B., et al. Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet 1980;1:441444.
  • 19
    von Schacky C., Fischer S., Weber PC. Long-term effects of dietary marine n-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 1985;76:16261631.
  • 20
    Goodnight SH, Harris WS, Connor WE. The effects of dietary n-3 fatty acids on platelet composition and function in man: A prospective, controlled study. Blood 1981;58:880885.
  • 21
    Terano T., Hirai A., Hamazake T., et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity, and red cell deformability in healthy human subjects. Atherosclerosis 1983;46:321331.
  • 22
    Casali RE, Hale JA, LeNarz L., et al. Improved graft patency associated with altered platelet function induced by marine fatty acids in dogs. J Surg Res 1986;29:357358.
  • 23
    Honstra G. Influence of dietary fish oil on arterial thrombosis and atherosclerosis in animal models and in man. J Intern Med 1989;225:5359 (suppl).
  • 24
    Davidson BC, Haggan J. Dietary polyenoic fatty acids change the response of cat blood platelets to inductions of aggregation by ADP. Prostaglandins Leukot Essent Fatty Acids 1990;39:3137.
  • 25
    Black KL, Culp B., Madison D., et al. The protective effects of dietary fish oil on focal cerebral infarction. Prostaglandins 1979;3:257268.
  • 26
    McDonald TP. Effect of thrombopoietin on platelet size of mice. Exp Hematol 1980;8:527532.
  • 27
    Sullivan PS, McDonald TP. Acetylsalicylic acid stimulates murine megakaryocyte precursor cells. PSEBM 1990;194:216220.
  • 28
    MacDonald ML, Rogers QR, Morris JG. Role of linoleate as an essential fatty acid for the cat, independent of arachidonate synthesis. J Nutr 1983;113:14221433.
  • 29
    Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37: 911917.
  • 30
    Mielke CH, Kaneshire MM, Maher IA, et al. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969;34:204215.
  • 31
    Parker MT, Collier LL, Kier AB, et al. Oral mucosal bleeding times of normal cats and cats with Chediak-Higashi Syndrome or Hageman trait (factor XII deficiency). Vet Clin Path 1988;17:912.
  • 32
    Stroup WW. Why mixed models? In: Applications of Mixed Models in Agricultural and Related Disciplines. Baton Rouge: Southern Cooperative Series Bulletin No. 343, 1989:18.
  • 33
    McLean RA, Sanders WL, Stroup WW. A unified approach to mixed linear models. Am Statistician 1991;45:5464.
  • 34
    Hornstra G. Specific effects of types of dietary fat on arterial thrombosis. In: VergroesenAJ, ed. The Role of Fats in Human Nutrition. New York , NY : Academic; 1975:303330.
  • 35
    Clandinin MT, Cheema S., Field CJ, et al. Dietary fat: Exogenous determination of membrane structure and cell function. FASEB J 1991;5:27612769.
  • 36
    Stansby ME. Nutritional properties of fish oil. World Rev Nutr Diet 1969;11:46105.
  • 37
    Leaf A., Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988;318:549557.
  • 38
    von Schacky C., Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 1985;76:24462450.
  • 39
    Fischer S., Weber PC. Thromboxane A3(TXA3) is formed in human platelets after dietary eicosapentaenoic acid (20:5n3). Biochem Biophys Res Commun 1983;116: 10911099.
  • 40
    Fischer S., Weber PC. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 1984;307:165168.
  • 41
    Barcelli U., Glas-Greenwalt P., Pollack VE. Enhancing effect of dietary supplement with n-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb Res 1985;39:307312.
  • 42
    Lorenz R., Spengler U., Fischer S., et al. Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 1985;67:504511.
  • 43
    Kristensen SD, Schmidt EB, Dyerberg J. Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function. J Intern Med 1989;225:141150 (suppl).
  • 44
    Goodnight SH, Harris WS, Connor WE. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arterioscler 1982;2:87113.
  • 45
    Rivers JPW, Sinclair AJ, Crawford MA. Inability of the cat to desaturate essential fatty acids. Nature 1975;258:171173.
  • 46
    MacDonald ML, Anderson BC, Rogers QR, et al. Essential fatty acid requirements of cats: Pathology of essential fatty acidde-: ficiency. Am J Vet Res 1984;45:13101317.
  • 47
    Weidinger F., Glogar D., Sochor H., et al. Platelet survival in patients with dilated cardiomyopathy. Thromb Haemost 1991;66:400405.
  • 48
    Fox PR, Dodds WJ. Coagulopathies observed with spontaneous aortic embolism. Proc Am Coll Vet Int Med 1982;1:83.
  • 49
    Garrido A., Garate M., Campos R., et al. Increased susceptibility of cellular membranes to the induction of oxidative stress after ingestion of high doses offish oil. J Nutr Biochem 1993;4:118122.
  • 50
    Odeleye OE, Watson RR, Eskelson CD, et al. Dietary polyunsaturated fatty acids promote peroxidation and its possible role in the promotion of cancer. Adv Exp Med Biol 1991;283:789791.
  • 51
    Chang HR, Dulloo AG, Vladoianu IR, et al. Fish oil decreases natural resistance of mice to infection with Salmonella typhimurium. Metabolism 1992;41:12.